OpenVSafe by OpenVAERS
Search V-safe

D66-50030-42097

4 vaccinations 5 coded responses 32 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
293 / SC
Registered
2021-03-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2619793 (opens in a new window) high 10 / 11 3 4 of 9 VAERS symptoms same dose (4) OH differs 2022-04-23 / 2022-06-06 / 2023-04-24
received 3 days before the last call
case 578493

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-23
    Registered in v-safe
  3. 2021-03-23
    Health check-in — day 7, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  4. 2021-03-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-04-06
    Dose 2 — Pfizer-BioNTech
  6. 2021-04-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Tremor — Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Slight shakiness similar to an almost hypoglycemic feeling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Chills, Nausea
    Adult check-in
  8. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-04-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-05-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-18
    Survey response — day 42, dose 2
    MedDRA: Erythema, Injection site erythema, Injection site pruritus, Injection site vesicles, Pruritus, Scab — Feeling: Good
    Free text: The two spots where I got the vaccines blistered and formed tiny scabs just in the last week. The only reason I noticed is that the spots were itchy. The scabs are disappearing leaving two tiny reddish spots where I got the vaccinations.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-07-06
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-09-09
    Dose 3 — Pfizer-BioNTech
  20. 2021-10-05
    Survey response — 6 months, dose 2
    MedDRA: Cough, Exposure to SARS-CoV-2, Headache, Oropharyngeal pain, Pyrexia — Feeling: Good
    Free text: Symptoms consistent with extremely mild covid breakthrough. Out of caution I isolated for 10 days. Symptoms were sore throat, headache, 2 day cough, low fever 1 day. Exposed to covid. Better before I could get test. Lasted 4 days. SHOTS WORK!
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-10-06
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  22. 2021-10-07
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  23. 2021-10-14
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  24. 2021-10-21
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-12-09
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-03-10
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-04-23
    Dose 4 — Pfizer-BioNTech
  28. 2022-04-27
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  29. 2022-04-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  30. 2022-04-30
    Health check-in — day 7, dose 4
    Feeling: Good · Joint pains
    Adult check-in
  31. 2022-05-07
    Survey response — day 14, dose 4
    MedDRA: Nail discolouration — Feeling: Good
    Free text: My toenail turned red and then black after the 2nd booster.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-05-14
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-05-21
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-05-28
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-06-04
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-07-23
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  37. 2023-04-23
    Survey response — 12 months, dose 4
    MedDRA: Asthma, COVID-19, Fatigue, Gastrointestinal disorder, Headache, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  38. 2023-04-23
    Report sent to call center — 12 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  39. 2023-04-24
  40. 2023-04-27
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-03-16Pfizer-BioNTech
22021-04-06Pfizer-BioNTech
32021-09-09Pfizer-BioNTech No
42022-04-23Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-07

Systemic reaction (other): Slight shakiness similar to an almost hypoglycemic feeling

Release 8 — day 42, dose 2

2021-05-18

Symptoms: The two spots where I got the vaccines blistered and formed tiny scabs just in the last week. The only reason I noticed is that the spots were itchy. The scabs are disappearing leaving two tiny reddish spots where I got the vaccinations.

Release 10 — 6 months, dose 2

2021-10-05

Symptoms: Symptoms consistent with extremely mild covid breakthrough. Out of caution I isolated for 10 days. Symptoms were sore throat, headache, 2 day cough, low fever 1 day. Exposed to covid. Better before I could get test. Lasted 4 days. SHOTS WORK!

Release 11 — day 14, dose 4

2022-05-07

Symptoms: My toenail turned red and then black after the 2nd booster.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDErythema ✓ ✓ ✓
SDExposure to SARS-CoV-2 · · ✓
SDFatigue · · ✓
SDGastrointestinal disorder · · ✓
SDHeadache · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site vesicles ✓ ✓ ✓
SDNail discolouration · · ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease · · ✓
SDPruritus ✓ ✓ ✓
SDPyrexia · · ✓
SDScab ✓ ✓ ✓
SROTremor ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release